IRIS PubliCatt

Fianchi, Luana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.359
NA - Nord America 3.959
AS - Asia 1.042
SA - Sud America 31
AF - Africa 23
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.433
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.940
DE - Germania 1.902
SE - Svezia 791
CN - Cina 713
UA - Ucraina 357
IT - Italia 295
PL - Polonia 252
IE - Irlanda 193
FR - Francia 185
GB - Regno Unito 139
SG - Singapore 118
IN - India 94
FI - Finlandia 93
RU - Federazione Russa 53
TR - Turchia 35
JP - Giappone 25
BE - Belgio 17
NL - Olanda 17
ES - Italia 16
CI - Costa d'Avorio 15
AU - Australia 13
BR - Brasile 12
HK - Hong Kong 11
CA - Canada 10
KR - Corea 10
IR - Iran 9
MX - Messico 8
RO - Romania 8
VN - Vietnam 8
CZ - Repubblica Ceca 7
NO - Norvegia 6
TH - Thailandia 6
BG - Bulgaria 5
CL - Cile 5
CO - Colombia 5
IL - Israele 5
ZA - Sudafrica 5
AT - Austria 4
GR - Grecia 4
HU - Ungheria 4
AR - Argentina 3
CH - Svizzera 3
EC - Ecuador 2
EG - Egitto 2
EU - Europa 2
HR - Croazia 2
ID - Indonesia 2
LU - Lussemburgo 2
MY - Malesia 2
NZ - Nuova Zelanda 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BO - Bolivia 1
IS - Islanda 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.433
Salva come PNG Salva come JPEG
Città #
Chandler 811
Ashburn 270
Jacksonville 260
Warsaw 248
San Mateo 184
Dublin 181
Ann Arbor 172
Dearborn 159
Nanjing 155
Wilmington 141
Houston 120
Nürnberg 120
Woodbridge 108
New York 107
Beijing 82
Fairfield 80
Boston 76
Bremen 75
Milan 73
Singapore 67
Lawrence 66
Seattle 64
Cattolica 61
Nanchang 53
Redwood City 50
Zhengzhou 46
Redmond 45
Marseille 41
Munich 38
Shenyang 38
Moscow 37
Princeton 37
Kunming 36
Hangzhou 35
Lancaster 32
Los Angeles 31
Leawood 30
Shanghai 30
Cambridge 29
Chicago 28
Hebei 26
Auburn Hills 25
Izmir 24
Boardman 23
Jiaxing 21
Mountain View 21
Tianjin 21
Augusta 19
Hefei 19
Norwalk 19
Rome 19
Falls Church 18
University Park 18
Brussels 17
Changsha 16
Chatsworth 16
Pune 16
Abidjan 15
Philadelphia 15
Guangzhou 14
Jinan 13
Fremont 11
Hong Kong 10
Simi Valley 10
São Paulo 8
Costa Mesa 7
Edinburgh 7
Lanzhou 7
London 7
Monmouth Junction 7
Washington 7
Enterprise 6
Hanoi 6
Helsinki 6
Kansas City 6
Lappeenranta 6
Ningbo 6
San Diego 6
San Francisco 6
San Jose 6
Taizhou 6
Tokyo 6
Amsterdam 5
Andover 5
Bari 5
Chengdu 5
Phoenix 5
Seoul 5
Budapest 4
Changchun 4
Cuauhtémoc 4
Kish 4
Madrid 4
Mumbai 4
Sacramento 4
Seo-gu 4
Southend 4
Bologna 3
Brooklyn 3
Buffalo 3
Totale 4.933
Salva come PNG Salva come JPEG
Nome #
Incidence of acute myeloid leukemia after breast cancer 333
Factors associated with mortality in bacteremic patients with haematologic malignancies 294
Factors associated with mortality in bacteremic patients with hematologic malignancies. 294
Fanconi anemia gene variants in therapy-related myeloid neoplasms 252
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 198
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 166
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 166
Factors associated with mortality in bacteremic patients with hematologic malignancies. 158
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 155
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 152
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 134
Why methylation is not a marker predictive of response to hypomethylating agents 133
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 130
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 130
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 129
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 129
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 128
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 127
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 120
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 120
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 120
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 120
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 118
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 112
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 111
Primary plasma cell leukemia followed by testicular plasmacytoma 107
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 106
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 105
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 104
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 104
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 101
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 101
Epigenetic changes in therapy-related MDS/AML 100
Similarities and differences between therapy-related and elderly acute myeloid leukemia 100
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 99
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 99
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 98
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 96
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 92
Outcome of therapy-related myeloid neoplasms treated with azacitidine 91
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 90
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 90
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 88
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 86
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 84
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 84
Clonal evolution in therapy-related neoplasms 84
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 83
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 83
Small lymphocytic lymphoma in a patient with Fabry disease 82
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 79
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 79
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 79
Small lymphocytic lymphoma in a patient with Fabry disease 77
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 77
Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine 76
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 75
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 75
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 75
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 72
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 71
High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study 70
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 68
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 68
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 66
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 64
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 64
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 64
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia 63
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 61
Therapy-related myeloid neoplasms 60
Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin 59
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 58
Therapy-related myeloid neoplasms: Clinical perspectives 56
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 55
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 55
. Pulmonary aspergillosis: lights and shadows 54
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 54
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 53
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 53
The role of neutrophils in the development and outcome of zygomycosis in haematological patients 52
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 52
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 52
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 52
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 51
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 51
Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis 51
ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies. 50
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis 50
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient 46
Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium 45
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 45
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 43
Breakthrough zygomycosis and voriconazole 40
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 40
Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium 37
Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium 36
Fungal pneumonia due to molds in patients with hematological malignancies. 35
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 34
Real-Life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile 33
Totale 9.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.606 271 121 97 127 166 198 125 59 113 106 117 106
2020/20211.089 40 93 24 88 136 118 133 29 105 58 231 34
2021/20221.028 108 69 12 43 75 49 26 164 55 85 141 201
2022/20232.152 270 303 185 382 151 255 81 182 232 17 72 22
2023/2024972 50 272 32 31 29 195 53 23 12 27 126 122
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 9.545